TY  - GEN
AU  - Kaufmann,M
AU  - Maass,N
AU  - Costa,S D
AU  - Schneeweiss,A
AU  - Loibl,S
AU  - Sütterlin,M W
AU  - Schrader,I
AU  - Gerber,B
AU  - Bauer,W
AU  - Wiest,W
AU  - Tomé,O
AU  - Distelrath,A
AU  - Hagen,V
AU  - Kleine-Tebbe,A
AU  - Ruckhaeberle,E
AU  - Mehta,K
AU  - von Minckwitz,G
TI  - First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial
SN  - 1879-0852
PY  - 2011///0509
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Breast Neoplasms, Male
KW  - Capecitabine
KW  - Deoxycytidine
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Prospective Studies
KW  - Quality of Life
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ejca.2010.07.009
ER  -